Sol Langermann - Jan 31, 2022 Form 4 Insider Report for NextCure, Inc. (NXTC)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NXTC	Employee Stock Option (Right to Buy)	Award	$0	+117K		$0.00	117K	Jan 31, 2022	Common Stock	117K	$5.57	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	One fourth of the option vests on January 31, 2023. The remainder vests in 36 monthly installments beginning on February 28, 2023.